antiparkinson/obesity

OBJECTIVE Some Parkinson's disease patients may develop morbid obesity, on account of the reduction in exercise and/or of the appearance of compulsive food intake in the first years after diagnosis. The prescription of central appetite suppressants is actually not recommended in Parkinson's disease

UNASSIGNED The association of vascular risk factors (VRFs) with incidence of Alzheimer's disease (AD) and vascular dementia (VaD) has been well studied. However, the association between VRFs and non-AD dementia is seldom investigated. In this study, we aim to compare the concurrence of VRFs of Lewy

The 39th Annual Meeting of the Society for Neuroscience (SFN), held in Chicago, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on novel neuroprotective and antiparkinsonian agents, and compounds in

OBJECTIVE To evaluate the current rate of underweightness amongst Parkinson's disease (PD) patients at an Italian referral centre. METHODS Epidemiological study on consecutive patients presenting for the first time in a 16-month period. METHODS Nutritional service of PD referral centre in Milan,